ITMI952614A0 - - Google Patents

Info

Publication number
ITMI952614A0
ITMI952614A0 ITMI952614A ITMI952614A ITMI952614A0 IT MI952614 A0 ITMI952614 A0 IT MI952614A0 IT MI952614 A ITMI952614 A IT MI952614A IT MI952614 A ITMI952614 A IT MI952614A IT MI952614 A0 ITMI952614 A0 IT MI952614A0
Authority
IT
Italy
Application number
ITMI952614A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI952614A0 publication Critical patent/ITMI952614A0/it
Publication of ITMI952614A1 publication Critical patent/ITMI952614A1/it
Application granted granted Critical
Publication of IT1277073B1 publication Critical patent/IT1277073B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048Pyridine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT95MI002614A 1994-12-23 1995-12-13 Derivati antraciclinici IT1277073B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9426075A GB2296495B (en) 1994-12-23 1994-12-23 Anthracycline derivatives

Publications (3)

Publication Number Publication Date
ITMI952614A0 true ITMI952614A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1995-12-13
ITMI952614A1 ITMI952614A1 (it) 1997-06-13
IT1277073B1 IT1277073B1 (it) 1997-11-04

Family

ID=10766488

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI002614A IT1277073B1 (it) 1994-12-23 1995-12-13 Derivati antraciclinici

Country Status (4)

Country Link
JP (1) JP4081148B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE19547958B4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2296495B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1277073B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315067B (en) * 1996-07-11 2000-02-16 Pharmacia Spa Morpholinyl anthracycline derivatives
AU767394C (en) * 1999-12-29 2005-04-21 Immunogen, Inc. Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
CA2519310A1 (en) * 2003-03-18 2004-09-30 Maria Adele Pacciarini Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor
MXPA05009851A (es) * 2003-03-18 2005-12-06 Pharmacia Italia Spa Como radiosensibilizador en combinacion con terapia con radiacion contra tumores.
WO2009099741A1 (en) 2008-02-01 2009-08-13 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
JP5647971B2 (ja) * 2008-04-11 2015-01-07 天津和美生物技▲術▼有限公司Tianjin Hemay Bio−Tech Co.Ltd 高活性アントラサイクリン系抗生物質の誘導体、該誘導体の製造及び応用
EP2277884B1 (en) * 2008-04-11 2017-08-23 Tianjin Hemay Oncology Pharmaceutical Co., Ltd Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof
ES2532635T3 (es) 2008-07-15 2015-03-30 Genentech, Inc. Conjugados de antraciclina, proceso para su preparación y su uso como compuestos antitumorales
BR112013013127B1 (pt) 2010-12-02 2021-06-22 Nerviano Medical Sciences S.R.L. Processo para a preparação de derivados de morfolinil antraciclina, compostos derivados de morfolinil antraciclina e composição farmacêutica compreendendo estes compostos
JP6104287B2 (ja) * 2012-03-06 2017-03-29 天津和美生物技術有限公司 四環系アントラキノン誘導体
ES2695162T3 (es) 2013-04-29 2019-01-02 Nerviano Medical Sciences Srl Nuevos derivados de morfolinil antraciclina
JP6785780B2 (ja) 2014-11-05 2020-11-18 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 官能基化モルホリニルアントラサイクリン誘導体
CN110776501B (zh) * 2019-08-22 2021-04-02 联宁(苏州)生物制药有限公司 一种用于抗体药物偶联物的药物毒素pnu-159682的制备方法及其中间体
WO2025092728A1 (zh) * 2023-10-30 2025-05-08 上海皓元生物医药科技有限公司 一种pnu-159682的中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301277A (en) * 1980-10-20 1981-11-17 Sri International 3-Deamino-3-(4-morpholinyl) derivatives of daunorubicin and doxorubicin
JPS57163393A (en) * 1981-03-27 1982-10-07 Microbial Chem Res Found Novel anthracyclin derivative and its preparation
JPS59212499A (ja) * 1983-05-13 1984-12-01 アドリヤ・ラボラトリ−ズ・インコ−ポレ−テツド 抗腫瘍性抗生物質アントラサイクリンの4−デメトキシ−3′−デアミノ−3′(4−モリホリニル)誘導体
US4585859A (en) * 1983-05-24 1986-04-29 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin

Also Published As

Publication number Publication date
JP4081148B2 (ja) 2008-04-23
DE19547958B4 (de) 2015-01-22
GB2296495B (en) 1998-04-15
DE19547958A1 (de) 1996-06-27
IT1277073B1 (it) 1997-11-04
ITMI952614A1 (it) 1997-06-13
JPH08231581A (ja) 1996-09-10
GB2296495A (en) 1996-07-03
GB9426075D0 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
DK0677466T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0666525A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0669187A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0671407A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0671801A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI952614A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW278284B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0667387A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE69535748D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0667627A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW236711B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI950685V0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ITMI952573A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN182530B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI940184S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI940191S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN179244B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI940192S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSDI940198S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN187331B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ECSMU940035U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0662420A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR7402097U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN189689B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0668153A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
0001 Granted